KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $845.0 million.

  • Cvs Health's Dividends Paid - Common rose 83.53% to $845.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 71.15%. This contributed to the annual value of $3.4 billion for FY2025, which is 71.15% up from last year.
  • As of Q4 2025, Cvs Health's Dividends Paid - Common stood at $845.0 million, which was up 83.53% from $846.0 million recorded in Q3 2025.
  • Over the past 5 years, Cvs Health's Dividends Paid - Common peaked at $866.0 million during Q2 2025, and registered a low of $650.0 million during Q2 2021.
  • For the 5-year period, Cvs Health's Dividends Paid - Common averaged around $771.7 million, with its median value being $779.0 million (2023).
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first plummeted by 196.08% in 2021, then skyrocketed by 1384.62% in 2022.
  • Over the past 5 years, Cvs Health's Dividends Paid - Common (Quarter) stood at $660.0 million in 2021, then increased by 8.94% to $719.0 million in 2022, then increased by 8.34% to $779.0 million in 2023, then rose by 7.57% to $838.0 million in 2024, then rose by 0.84% to $845.0 million in 2025.
  • Its Dividends Paid - Common was $845.0 million in Q4 2025, compared to $846.0 million in Q3 2025 and $866.0 million in Q2 2025.